- Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
-
Santos NCd, Miravitlles M, Camelier AA, Almeida VDCd, Maciel RRBT, Camelier FWR
- KMID: 2531449
- Tuberc Respir Dis.
- 2022 Jul;85(3):205-220.
- doi: 10.4046/trd.2021.0179
This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?
-
Miravitlles M, Baek S, Vithlani V, Lad R
- KMID: 2414562
- Tuberc Respir Dis.
- 2018 Jul;81(3):198-215.
- doi: 10.4046/trd.2018.0040
Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic... -
- CITED
-
- Close
- SHARE
-
- Close
